CO2 correction is a vital component of accurate hydrogen and methane breath testing, and at CDI, we lead the way in implementing this essential process. By choosing CDI, healthcare providers can trust that they receive the most accurate, reliable, and transparent diagnostic results, enabling them to deliver exceptional patient care. Breath testing has become a…
Breath testing in pediatric cases represents a significant advancement in diagnosing functional gastrointestinal (GI) disorders, including Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and carbohydrate malabsorption. These tests offer a non-invasive, patient-friendly alternative to more invasive diagnostic methods, providing a crucial tool for pediatric gastroenterologists to diagnose and manage GI disorders effectively. Benefits…
Breath testing for methane provides indispensable insights into the presence and severity of Intestinal Methanogen Overgrowth, highlighting its critical role in modern gastroenterology. As research advances and clinical practices evolve, breath testing remains a cornerstone in diagnosing and managing IMO, offering a more straightforward path towards optimal patient care. Intestinal Methanogen Overgrowth (IMO), formally…
Linking hydrogen and methane breath testing and nutritional management offers a powerful, patient-centered approach to GI health. By combining precise diagnostic insights with tailored dietary strategies, healthcare providers can address the multifaceted nature of functional GI disorders, promoting long-term wellness and patient satisfaction. This holistic method underscores the importance of considering the entire patient picture…
In the intricate journey of Small Intestinal Bacterial Overgrowth (SIBO) diagnosis and treatment, breath testing has become a beacon of clarity and a distinguishing factor in better managing these cases. A recent study published in the Journal of Neurogastroenterology and Motility reinforces the pivotal role of breath tests in diagnosing SIBO and as a crucial…
After years of industry advocacy with the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), healthcare providers now have dedicated ICD-10 codes for intestinal microbial overgrowth and its subsets, including Small Intestinal Bacterial Overgrowth (SIBO) and Intestinal Methanogen Overgrowth (IMO). The following provides a comprehensive guide to the updates under…
According to the Rome IV classification of the disorders of the gut-brain interaction (DGBI), there are 33 adult and 20 pediatric DGBIs. Each of the DGBIs is then organized into anatomical domains. As part of CDI’s efforts to raise awareness for Irritable Bowel Syndrome (IBS) during IBS Awareness Month, we are sharing the following definitions…
The North American Consensus on Breath Testing recommends using a hydrogen and methane breath test to detect Small Intestinal Bacterial Overgrowth (SIBO), abnormal growth of bacteria in a patient’s small intestine, and Intestinal Methanogen Overgrowth (IMO), excessive levels of methane in a patient’s intestinal tract. Both SIBO and IMO can cause various symptoms in patients,…
Hydrogen-methane breath testing is valuable in clinical care for diagnosing small intestinal bacterial overgrowth (SIBO) and guiding treatment decisions. A recent paper by Tansel and Levinthal in Clinical and Translational Gastroenterology provides insights into the practical application of breath testing in real-world clinical scenarios, offering valuable information for gastroenterologists, dietitians, nutritionists, and other allied health…
Small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) commonly cause digestive symptoms like bloating, abdominal pain, and changes in bowel movements. SIBO and IMO are defined as an over-accumulation of bacteria and archaea, respectively, in the small intestine. Research has concluded that up to 36 million Americans suffer from SIBO. At-home breath testing can diagnose…
